01530.HK
3SBio Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 16.24
−0.31%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 13.62x
- P/E 2027E
- 12.79x
- P/E 2028E
- 11.02x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 3.24x
- PEG TTM
- 0.05x
- Price / book
- 1.23x
- Price / sales
- 1.25x
- Price / cash flow
- 3.49x
Enterprise value
- Enterprise value
- HKD 23.4B
- EV / sales
- 0.75x
- EV / EBITDA
- 1.42x
- EV / EBIT
- 1.51x
- Market cap
- HKD 39.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026